- Home
- SANW vs TENX Comparison
SANW vs TENX Comparison
Compare SANW & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANW
- TENX
- Stock Information
- Founded
- SANW 1980
- TENX 1967
- Country
- SANW United States
- TENX United States
- Employees
- SANW N/A
- TENX N/A
- Industry
- SANW Farming/Seeds/Milling
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SANW Consumer Staples
- TENX Health Care
- Exchange
- SANW Nasdaq
- TENX Nasdaq
- Market Cap
- SANW 18.8M
- TENX 21.7M
- IPO Year
- SANW 2010
- TENX N/A
- Fundamental
- Price
- SANW $7.12
- TENX $6.36
- Analyst Decision
- SANW Strong Buy
- TENX Strong Buy
- Analyst Count
- SANW 1
- TENX 3
- Target Price
- SANW $35.00
- TENX $16.00
- AVG Volume (30 Days)
- SANW 6.2K
- TENX 43.8K
- Earning Date
- SANW 05-13-2025
- TENX 03-25-2025
- Dividend Yield
- SANW N/A
- TENX N/A
- EPS Growth
- SANW N/A
- TENX N/A
- EPS
- SANW N/A
- TENX N/A
- Revenue
- SANW $54,809,365.00
- TENX N/A
- Revenue This Year
- SANW N/A
- TENX N/A
- Revenue Next Year
- SANW $9.92
- TENX N/A
- P/E Ratio
- SANW N/A
- TENX N/A
- Revenue Growth
- SANW N/A
- TENX N/A
- 52 Week Low
- SANW $2.10
- TENX $2.77
- 52 Week High
- SANW $11.60
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- SANW 44.22
- TENX 50.58
- Support Level
- SANW $6.73
- TENX $6.00
- Resistance Level
- SANW $8.22
- TENX $6.76
- Average True Range (ATR)
- SANW 0.67
- TENX 0.42
- MACD
- SANW -0.04
- TENX 0.02
- Stochastic Oscillator
- SANW 37.50
- TENX 47.37
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.